Electro-Optical Sciences, Inc. Announces Participation at the Oppenheimer 19th Annual Healthcare Conference

IRVINGTON, NY--(Marketwire - October 22, 2008) - Electro-Optical Sciences, Inc. ("EOS") (NASDAQ: MELA), a medical device company focused on the design and development of MelaFind®, a non-invasive, point-of-care instrument to assist in the early diagnosis of melanoma, today announced that Joseph V. Gulfo, MD, MBA, president and chief executive officer, will present at the Oppenheimer 19th Annual Healthcare Conference taking place at the Waldorf Astoria hotel in New York City on November 3-4, 2008.
MORE ON THIS TOPIC